252 related articles for article (PubMed ID: 28866033)
1. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
[No Abstract] [Full Text] [Related]
2. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
Sato T; Richardt G; Abdel-Wahab M
Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
[No Abstract] [Full Text] [Related]
3. Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months.
Kang SH; Kang SJ; Kim WJ
JACC Cardiovasc Interv; 2017 Sep; 10(18):1896-1898. PubMed ID: 28866035
[No Abstract] [Full Text] [Related]
4. Subintimal Crush of an Occluded Stent to Recanalize a Chronic Total Occlusion Due to In-Stent Restenosis: Insights From a Multimodality Imaging Approach.
Capretti G; Mitomo S; Giglio M; Carlino M; Colombo A; Azzalini L
JACC Cardiovasc Interv; 2017 Apr; 10(8):e81-e83. PubMed ID: 28365267
[No Abstract] [Full Text] [Related]
5. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
[No Abstract] [Full Text] [Related]
6. Multiple Mechanisms in 1 In-Stent Restenosis Assessed by Optical Coherence Tomography.
Lu WD; Huang CW; Li YH; Chen JY
JACC Cardiovasc Interv; 2017 Nov; 10(22):2340-2341. PubMed ID: 29102578
[No Abstract] [Full Text] [Related]
7. Illustration of the Resorption Process Between 2 Different Overlapping Bioresorbable Scaffolds.
Tanaka A; Jabbour RJ; Kawamoto H; Latib A; Colombo A
JACC Cardiovasc Imaging; 2016 Dec; 9(12):1469-1470. PubMed ID: 27085427
[No Abstract] [Full Text] [Related]
8. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
[TBL] [Abstract][Full Text] [Related]
9. Very Late Restenosis After Bioresorbable Scaffold Implantation Due to Simultaneous External Compression of the Scaffold and Intrascaffold Tissue Growth.
Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
JACC Cardiovasc Interv; 2016 Jan; 9(2):e15-7. PubMed ID: 26723762
[No Abstract] [Full Text] [Related]
10. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
Lee WC; Fang HY; Fang CY
Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
[No Abstract] [Full Text] [Related]
11. Left Main restenosis in the DES era - a call for action.
di Palma G; Cortese B
Cardiovasc Revasc Med; 2018 Jun; 19(4):466-470. PubMed ID: 29169984
[TBL] [Abstract][Full Text] [Related]
12. Different Absorption Time of two Absorb BVS Implanted in the Same Artery: Insights into Mechanisms of Late Scaffold Failure.
Gąsior P; Parma R; Roleder T; Wojakowski W
Kardiol Pol; 2018; 76(8):1277. PubMed ID: 30117525
[No Abstract] [Full Text] [Related]
13. A broken promise: 4-year optical coherence tomography follow-up of a bioresorbable vascular scaffold.
Versaci F; Vizzari G; Prati F; Biondi-Zoccai G
J Cardiovasc Med (Hagerstown); 2020 May; 21(5):398-400. PubMed ID: 32243342
[No Abstract] [Full Text] [Related]
14. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.
Yamaji K; Brugaletta S; Sabaté M; Iñiguez A; Jensen LO; Cequier A; Hofma SH; Christiansen EH; Suttorp M; van Es GA; Sotomi Y; Onuma Y; Serruys PW; Windecker S; Räber L
JACC Cardiovasc Interv; 2017 Sep; 10(18):1867-1877. PubMed ID: 28935079
[TBL] [Abstract][Full Text] [Related]
15. First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.
Moscarella E; Ielasi A; Cortese B; De Angelis MC; Varricchio A
Coron Artery Dis; 2017 Aug; 28(5):437-439. PubMed ID: 28574901
[No Abstract] [Full Text] [Related]
16. Very late scaffold thrombosis: insights from optical coherence tomography and histopathology.
Joner M; Nicol P; Rai H; Richter H; Foin N; Ng J; Cuesta J; Rivero F; Serrano R; Alfonso F
EuroIntervention; 2018 Apr; 13(18):e2169-e2173. PubMed ID: 29155382
[No Abstract] [Full Text] [Related]
17. Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.
Bastante T; Rivero F; Benedicto A; Cuesta J; Alfonso F
JACC Cardiovasc Interv; 2015 Aug; 8(9):1264-1265. PubMed ID: 26292592
[No Abstract] [Full Text] [Related]
18. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
[No Abstract] [Full Text] [Related]
19. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
[No Abstract] [Full Text] [Related]
20. In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution?
Granata F; Moscarella E; Varricchio A
Coron Artery Dis; 2015 Aug; 26(5):461-2. PubMed ID: 25816019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
